Pancreatic Cancer Research

ResearcherJesse Brown VA Medical CenterActive in the last 2 years

Mario A. Shields

Matched on ORCID iD 0000-0002-3562-9875; OpenAlex author ID A5020129454; NIH RePORTER profile ID 15813051. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
1
Labs led
2
Collaborators
20
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper, 1 grant

Papers 10

  1. DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines. Co-author DOI 10.1016/j.canlet.2026.218666↗
  2. Targeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-3574↗
  3. Trametinib Potentiates Anti-PD-1 Efficacy in Tumors Established from Chemotherapy-Primed Pancreatic Cancer Cells. Co-author DOI 10.1158/1535-7163.mct-23-0833↗
  4. Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin. Co-author DOI 10.1016/j.celrep.2022.110441↗
  5. Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies. First author DOI 10.3390/cancers13030440↗
  6. Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression. First author DOI 10.1016/j.jss.2011.09.020↗
  7. Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Co-author DOI 10.1042/bj20111240↗
  8. Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins. Co-author DOI 10.1074/jbc.m111.308940↗
  9. Pancreatic cancer cells respond to type I collagen by inducing snail expression to promote membrane type 1 matrix metalloproteinase-dependent collagen invasion. Co-author DOI 10.1074/jbc.m110.195628↗
  10. Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Co-author DOI 10.1158/0008-5472.can-10-1855↗

Grants 1

  1. Elucidating the mechanism of Ga13 mediated tumor suppression in pancreatic cancer R01CA283925↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hidayatullah G. Munshi · 9 shared papers, 2011–2024 · strength 0.95
  2. Thao D. Pham · 4 shared papers, 2021–2024 · strength 0.76
  3. David J. Bentrem · 6 shared papers, 2011–2024 · strength 0.49
  4. Jeffrey H. Becker · 2 shared papers, 2024 · strength 0.45
  5. Daniel R. Principe · 2 shared papers, 2021–2024 · strength 0.36
  6. Rémy Nicolle · 1 shared paper, 2026 · strength 0.24
  7. Sofia Ferreira · 1 shared paper, 2026 · strength 0.24
  8. Ilianna Zoi · 1 shared paper, 2026 · strength 0.24
  9. Marc P. Stemmler · 1 shared paper, 2026 · strength 0.24
  10. Malak Haidar · 1 shared paper, 2026 · strength 0.24
  11. Ben Z. Stanger · 1 shared paper, 2026 · strength 0.24
  12. Janel L. Kopp · 1 shared paper, 2026 · strength 0.24
  13. Laura D Attardi · 1 shared paper, 2026 · strength 0.24
  14. Patrick Jacquemin · 1 shared paper, 2026 · strength 0.24
  15. Dhavan Shah · 1 shared paper, 2024 · strength 0.22
  16. Surabhi Y. Dangi-Garimella · 5 shared papers, 2011–2012 · strength 0.19
  17. Seth B. Krantz · 4 shared papers, 2011–2012 · strength 0.14
  18. Patrick W. Underwood · 1 shared paper, 2021 · strength 0.13
  19. Jose Gilberto Trevino · 1 shared paper, 2021 · strength 0.13
  20. Paul J. Grippo · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.